CWP/CANDDID members appointed to medication trial for autistic adults
The National Institute for Health Research (NIHR) Evaluation, Trials and Studies Co-ordinating Centre (NETSCC) has confirmed that Dr Sujeet Jaydeokar and Dr Ian Davidson have been nominated and formally appointed as a member of the Trial Steering Committee and a member of the Data Monitoring (and Ethics) Committee (DM(E)C) respectively as part of a multicentre double-blind placebo-controlled randomised trial of Sertraline for anxiety in adults with Autism (STRATA), HTA Project: NIHR127337.
The study aims to find out whether the drug sertraline is an effective treatment for anxiety in adults with a diagnosis of autism. Sertraline is a commonly prescribed antidepressant and is also recommended for the treatment of anxiety problems. Medications for anxiety are often prescribed for autistic adults but their effectiveness or side effects in this population are not well known.
For more information, please follow the link: https://fundingawards.nihr.ac.uk/award/NIHR127337